BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Orthop. Nov 18, 2026; 17(11): 118182
Published online Nov 18, 2026. doi: 10.5312/wjo.118182
Table 3 Histopathological evaluation of bone defect healing and composite/xenograft resorption and remodeling at 90 days, n (%)/mean ± SD

Control (n = 11)
Xenograft (n = 11)
Composite (n = 11)
P value
Closure of cortical defect (%)
Bone tissue
< 300 (0)0 (0)0 (0)aP = 0.217; bP = 0.365; cP = 0.699
30-500 (0)0 (0)0 (0)
51-801 (9.1)0 (0)2 (18.2)
> 8010 (91.9)11 (100)9 (81.8)
Cartilage tissue
< 3011 (100)11 (100)11 (100)
30-500 (0)0 (0)0 (0)
51-800 (0)0 (0)0 (0)
> 800 (0)0 (0)0 (0)
Fibrous tissue
< 3011 (100)11 (100)11 (100)
30-500 (0)0 (0)0 (0)
51-800 (0)0 (0)0 (0)
> 800 (0)0 (0)0 (0)
Fibroplastic barrier
No11 (100)11 (100)11 (100)
Yes0 (0)0 (0)0 (0)
Migration of composite/xenograft
Intramedullary0 (0)0.3 ± 0.5aP = 0.010; bP = 0.300; cP = 0.065
No displacement11 (100)8 (72.7)
Local displacement0 (0)3 (27.3)
Moderate migration0 (0)0 (0)
Pronounced migration0 (0)0 (0)
Extraosseous migration0
Absence11 (100)11 (100)aP = 0.748; bP = 1.00; cP = 0.748
Presence0 (0)0 (0)


Write to the Help Desk